Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0500 - 0.0500 |
52-week range | 0.0400 - 0.0600 |
Volume | |
Avg. volume | 388 |
Market cap | 13.116M |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MISSISSAUGA, Ontario, May 31, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be extended by up to 30 days. The Company has already received Conditional Acceptance for the placement from the TSX-V, but closing for the full amount of the proposed Placement has been delayed. The proposed pl
MISSISSAUGA, Ontario, May 01, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit ("Unit"). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Commo
MISSISSAUGA, Ontario, February 28, 2024--MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce they have successfully completed the pilot project with Health Partners. MedX and Health Partners are working together to begin the roll-out of this service to targeted clients engaged in a preventative approach to health care management.